| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $521K | -99.3% |
| R&D Expense | $140.4M | +37.5% |
| SG&A Expense | $38.8M | +20.8% |
| Operating Income | -$178.7M | -181.9% |
| Pre-tax Income | -$151.7M | -157.3% |
| Income Tax | $380K | +467.2% |
| Net Income | -$152.1M | -157.6% |
| EPS (Basic) | -$3.59 | -131.6% |
| EPS (Diluted) | -$3.59 | -131.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.6M | -1.2% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $716.9M | +97.9% |
| Total Assets | $722.5M | +96.0% |
| Current Liabilities | $24.8M | +44.7% |
| Total Liabilities | $25.5M | +30.9% |
| Stockholders' Equity | $697.0M | +99.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$112.3M | -11.2% |
| Capital Expenditures | $1.2M | +240.0% |
| Investing Cash Flow | -$341.8M | -505.5% |
| Financing Cash Flow | $453.4M | +901.7% |
| Free Cash Flow | -$113.6M | -12.0% |